+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Poultry Vaccines Market Size, Share & Trends Analysis Report by Product (Attenuated Live Vaccines, Inactivated Vaccines, Recombinant Vaccines), by Disease Type, by Application, by Region, and Segment Forecasts, 2022-2030

  • PDF Icon

    Report

  • 150 Pages
  • March 2022
  • Region: Global
  • Grand View Research
  • ID: 5569709
The global poultry vaccines market size is expected to reach USD 3.39 billion by 2030. The market is expected to expand at a CAGR of 7.1% from 2022 to 2030. The key factors driving the market include the rising consumption of poultry meat and eggs, the prevalence of avian diseases, and the increasing poultry population in key markets. According to OECD-FAO Agricultural Outlook, poultry meat consumption in the U.S. was pegged at 19,169 thousand tons in 2020. This consumption is projected to increase over the next few years.



The COVID-19 pandemic resulted in several challenges for the poultry industry including a fall in consumption, increased concerns over zoonoses, and low sales. For example, as per the Economic Times, in March 2020, the price of chicken plunged by as much as 70% due to the reduced consumption of meat, fish, eggs, and chicken. However, the pandemic also led to the rising awareness regarding diseases in animals and increasing demand for safe and healthy poultry products. This is anticipated to create opportunities for poultry vaccines manufacturers as poultry farms must ensure healthy layer, broiler, and breeder stock. In fact, in April 2021, the CEO & MD of Hester Biosciences Ltd. stated that the market for poultry vaccines is set to grow significantly post COVID.

In addition, the advent of new vaccines, such as Salmonella-vectored vaccines, which protect domesticated birds against necrotic enteritis is anticipated to provide a growth platform to this market. In addition, the rising usage of poultry vaccines by research institutes and colleges, along with vaccination awareness programs, is fueling the growth of the market. For instance, in July 2019, the Veterinary College and Research Institute based in Madurai, India started vaccinating domesticated birds, predominantly chickens, to save farmers from suffering significant losses.

Technological advancements in poultry vaccines, rising demand for animal protein, concerns over food safety, animal welfare, and microbial resistance, increased focus on avian healthcare, and shift from treatment to the prevention of diseases are some of the other factors anticipated to create growth opportunities in the market. For instance, the TAbic Vaccines Line by Phibro Animal Health Corporation comprises 25+ vaccines for poultry for protection against Newcastle disease, infectious bronchitis, and other poultry diseases.

Poultry Vaccines Market Report Highlights

  • The increasing prevalence of infectious diseases in poultry and product developments in the field are anticipated to create growth opportunities in the market
  • By product, attenuated live vaccines held the largest revenue share in 2021 owing to their relatively low production cost and long duration of protection
  • The Egg Drop Syndrome (EDS) disease type segment is expected to register a lucrative growth rate over the forecast period due to the growing use of inactivated vaccines to prevent viral disease
  • As per the MSD Vet Manual, EDS vaccines can also be given in combination with other vaccines, such as those for Newcastle disease, thus increasing their adoption rate
  • The breeder application segment dominated the market in 2021 due to the increasing use of vaccines at breeder farms to secure the health of the poultry and increase farm’s productivity
  • Europe held the largest revenue share in 2021 due to favorable government policies, rising concerns of zoonoses, and initiatives by key companies

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment scope
1.1.2 Regional scope
1.1.3 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased database
1.3.2 internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.7 List of Secondary Sources
1.8 Objectives
Chapter 2 Executive Summary
2.1 Poultry Vaccines Market Summary
Chapter 3 Poultry Vaccines Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Penetration & Growth Prospect Mapping, 2021
3.3 Poultry Vaccines Market Dynamics
3.3.1 Market driver analysis
3.3.2 Market restraint analysis
3.3.3. Market opportunity analysis
3.3.4. Market challenge analysis
3.4 Poultry Vaccines Market Analysis Tools: Porters
3.4.1 Supplier Power
3.4.2. Buyer Power
3.4.3. Substitution Threat
3.4.4. Threat of New Entrants
3.4.5. Competitive Rivalry
3.5 Poultry Vaccines Industry Analysis-PEST (Political & Legal, Economic, Social, and Technological)
3.5.1 Political/Legal Landscape
3.5.2 Economic Landscape
3.5.3 Social Landscape
3.5.4 Technology Landscape
3.6. Regulatory Landscape
Chapter 4 COVID-19 Impact Analysis
4.1 COVID-19 Prevalence Analysis
4.2. Current Impact & Future Scenario
4.3. Impact on Market Players
Chapter 5 Poultry Vaccines Market: Segment Analysis, By Application, 2017-2030 (USD Million)
5.1 Application Market Share Analysis, 2021 & 2030
5.2 Poultry Vaccines market, by Application, 2017 to 2030
5.3 Broiler
5.3.1 Broiler market, 2017-2030 (USD Million)
5.4 Layer
5.4.1 Layer market, 2017-2030 (USD Million)
5.5 Breeder
5.5.1 Breeder market, 2017-2030 (USD Million)
Chapter 6 Poultry Vaccines Market: Segment Analysis, By Product, 2017-2030 (USD Million)
6.1 Product Market Share Analysis, 2021 & 2030
6.2 Poultry Vaccines market, by Product, 2017 to 2030
6.3 Attenuated Live Vaccines
6.3.1 Attenuated Live Vaccines market, 2017-2030 (USD Million)
6.4 Inactivated Vaccines
6.4.1 Inactivated Vaccines market, 2017-2030 (USD Million)
6.5 Subunit Vaccines
6.5.1 Subunit Vaccines market, 2017-2030 (USD Million)
6.6 DNA Vaccines
6.6.1 DNA Vaccines market, 2017-2030 (USD Million)
6.7 Recombinant Vaccines
6.7.1 Recombinant Vaccines market, 2017-2030 (USD Million)
Chapter 7 Poultry Vaccines Market: Segment Analysis, By Disease Type, 2017-2030 (USD Million)
7.1 Disease Type Market Share Analysis, 2021 & 2030
7.2 Poultry Vaccines Market, by Disease Type, 2017 to 2030
7.3 Infectious Bronchitis
7.3.1 Infectious Bronchitis market, 2017-2030 (USD Million)
7.4 Infectious Bursal Diseases
7.4.1 Infectious Bursal Diseases market, 2017-2030 (USD million)
7.5 Infectious Laryngotracheitis
7.5.1 Infectious Laryngotracheitis market, 2017-2030 (USD Million)
7.6 Egg Drop Syndrome
7.6.1 Egg Drop Syndrome market, 2017-2030 (USD Million)
7.7 Adenovirus
7.7.1 Adenovirus market, 2017-2030 (USD Million)
7.8 Duck Viral Enteritis
7.8.1 Duck Viral Enteritis market, 2017-2030 (USD Million)
7.9 Inclusion Body Hepatitis
7.9.1 Inclusion Body Hepatitis market, 2017-2030 (USD Million)
7.10 Coccidiosis
7.10.1 Coccidiosis market, 2017-2030 (USD Million)
7.11 Avian Influenza
7.11.1 Avian Influenza market, 2017-2030 (USD Million)
7.12 Marek's Disease
7.12.1 Marek's Disease market, 2017-2030 (USD Million)
7.13 Newcastle Disease
7.13.1 Newcastle Disease market, 2017-2030 (USD Million)
7.14 Salmonella
7.14.1 Salmonella market, 2017-2030 (USD Million)
7.15 Avian Encephalomyelitis
7.15.1 Avian Encephalomyelitis market, 2017-2030 (USD Million)
7.16 Fowl Cholera
7.16.1 Fowl Cholera market, 2017-2030 (USD Million)
Chapter 8 Poultry Vaccines Market: Regional Market Analysis 2017-2030 (USD Million)
8.1 Definition & Scope
8.2 Regional Movement Analysis, 2021 & 2030
8.3 Regional Market Snapshot
8.4 North America
8.4.1 North America Poultry Vaccines Market, 2017-2030 (USD Million)
8.4.2. U.S.
8.4.2.1 U.S. Poultry Vaccines Market, 2017-2030 (USD Million)
8.4.3 Canada
8.4.3.1 Canada Poultry Vaccines Market, 2017-2030 (USD Million)
8.5 Europe
8.5.1 Europe Poultry Vaccines Market, 2017-2030 (USD Million)
8.5.2 U.K.
8.5.2.1 U.K. Poultry Vaccines Market, 2017-2030 (USD Million)
8.5.3 Germany
8.5.3.1 Germany Poultry Vaccines Market, 2017-2030 (USD Million)
8.5.4 France
8.5.4.1 France Poultry Vaccines Market, 2017-2030 (USD Million)
8.5.5 Italy
8.5.5.1 Italy Poultry Vaccines Market, 2017-2030 (USD Million)
8.5.6 Spain
8.5.6.1 Spain Poultry Vaccines Market, 2017-2030 (USD Million)
8.5.7 Russia
8.5.7.1 Russia Poultry Vaccines Market, 2017-2030 (USD Million)
8.6 Asia Pacific
8.6.1 Asia Pacific Poultry Vaccines market, 2017-2030 (USD Million)
8.6.2 Japan
8.6.2.1 Japan Poultry Vaccines Market, 2017-2030 (USD Million)
8.6.3 China
8.6.3.1 China Poultry Vaccines Market, 2017-2030 (USD million)
8.6.4 India
8.6.4.1 India Poultry Vaccines Market, 2017-2030 (USD Million)
8.6.5 Australia
8.6.5.1 Australia Poultry Vaccines Market, 2017-2030 (USD Million)
8.7 Latin America
8.7.1 Latin America Poultry Vaccines Market, 2017-2030 (USD Million)
8.7.2 Brazil
8.7.2.1 Brazil Poultry Vaccines Market, 2017-2030 (USD Million)
8.7.3 Mexico
8.7.3.1 Mexico Poultry Vaccines Market, 2017-2030 (USD Million)
8.7.4 Argentina
8.7.4.1 Argentina Poultry Vaccines Market, 2017-2030 (USD Million)
8.8 MEA
8.8.1 MEA Poultry Vaccines Market, 2017-2030 (USD Million)
8.8.2 South Africa
8.8.2.1 South Africa Poultry Vaccines Market, 2017-2030 (USD Million)
8.8.3 Saudi Arabia
8.8.3.1 Saudi Arabia Poultry Vaccines Market, 2017-2030 (USD Million)
Chapter 9 Poultry Vaccines Market-Competitive Analysis
9.1 Market Participant Categorization
9.1.1. Company Market Position Analysis
9.1.2. Synergy Analysis: Major Deals & Strategic Alliances
9.1.3. Market Leaders
9.1.4. Innovators
9.2. List of Key Companies
Chapter 10 Poultry Vaccines Market-Company Profiles
10.1 Boehringer Ingelheim International GmbH
10.1.1 Company overview
10.1.2 Financial performance
10.1.3 Product benchmarking
10.1.4 Strategic initiatives
10.2 Ceva
10.2.1 Company overview
10.2.2 Financial performance
10.2.3 Product benchmarking
10.2.4 Strategic initiatives
10.3 Zoetis
10.3.1 Company overview
10.3.2 Financial performance
10.3.3 Product benchmarking
10.3.4 Strategic initiatives
10.4 Elanco
10.4.1 Company overview
10.4.2 Financial performance
10.4.3 Product benchmarking
10.4.4 Strategic initiatives
10.5 Intervet Inc., a Subsidiary of Merck & Co., Inc.
10.5.1 Company overview
10.5.2 Financial performance
10.5.3 Product benchmarking
10.5.4 Strategic initiatives
10.6 Hester Biosciences Limited
10.6.1 Company overview
10.6.2 Financial performance
10.6.3 Product benchmarking
10.6.4 Strategic initiatives
10.7 Vaxxinova International BV
10.7.1 Company overview
10.7.2 Financial performance
10.7.3 Product benchmarking
10.7.4 Strategic initiatives
10.8 Venkys India
10.8.1 Company overview
10.8.2 Financial performance
10.8.3 Product benchmarking
10.8.4 Strategic initiatives
10.9 Calier
10.9.1 Company overview
10.9.2 Financial performance
10.9.3 Product benchmarking
10.9.4 Strategic initiatives
10.10 KM Biologics
10.10.1 Company overview
10.10.2 Financial performance
10.10.3 Product benchmarking
10.10.4 Strategic initiatives
10.11 Phibro Animal Health Corporation
10.11.1 Company overview
10.11.2 Financial performance
10.11.3 Product benchmarking
10.11.4 Strategic initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of Key companies
Table 3 North America Poultry Vaccines market, by country, 2017-2030 (USD Million)
Table 4 North America Poultry Vaccines market, by product, 2017-2030 (USD Million)
Table 5 North America Poultry Vaccines market, by Disease Type, 2017-2030 (USD Million)
Table 6 North America Poultry Vaccines market, by application, 2017-2030 (USD Million)
Table 7 U.S. Poultry Vaccines market, by product, 2017-2030 (USD Million)
Table 8 U.S. Poultry Vaccines market, by Disease Type, 2017-2030 (USD Million)
Table 9 U.S. Poultry Vaccines market, by application, 2017-2030 (USD Million)
Table 10 Canada Poultry Vaccines market, by product, 2017-2030 (USD Million)
Table 11 Canada Poultry Vaccines market, by Disease Type, 2017-2030 (USD Million)
Table 12 Canada Poultry Vaccines market, by application, 2017-2030 (USD Million)
Table 13 Europe Poultry Vaccines market, by country, 2017-2030 (USD Million)
Table 14 Europe Poultry Vaccines market, by product, 2017-2030 (USD Million)
Table 15 Europe Poultry Vaccines market, by Disease Type, 2017-2030 (USD Million)
Table 16 Europe Poultry Vaccines market, by application, 2017-2030 (USD Million)
Table 17 U.K. Poultry Vaccines market, by product, 2017-2030 (USD Million)
Table 18 U.K. Poultry Vaccines market, by Disease Type, 2017-2030 (USD Million)
Table 19 U.K. Poultry Vaccines market, by application, 2017-2030 (USD Million)
Table 20 Germany Poultry Vaccines market, by product, 2017-2030 (USD Million)
Table 21 Germany Poultry Vaccines market, by Disease Type, 2017-2030 (USD Million)
Table 22 Germany Poultry Vaccines market, by application, 2017-2030 (USD Million)
Table 23 France Poultry Vaccines market, by product, 2017-2030 (USD Million)
Table 24 France Poultry Vaccines market, by Disease Type, 2017-2030 (USD Million)
Table 25 France Poultry Vaccines market, by application, 2017-2030 (USD Million)
Table 26 Italy Poultry Vaccines market, by product, 2017-2030 (USD Million)
Table 27 Italy Poultry Vaccines market, by Disease Type, 2017-2030 (USD Million)
Table 28 Italy Poultry Vaccines market, by application, 2017-2030 (USD Million)
Table 29 Spain Poultry Vaccines market, by product, 2017-2030 (USD Million)
Table 30 Spain Poultry Vaccines market, by Disease Type, 2017-2030 (USD Million)
Table 31 Spain Poultry Vaccines market, by application, 2017-2030 (USD Million)
Table 32 Russia Poultry Vaccines market, by product, 2017-2030 (USD Million)
Table 33 Russia Poultry Vaccines market, by Disease Type, 2017-2030 (USD Million)
Table 34 Russia Poultry Vaccines market, by application, 2017-2030 (USD Million)
Table 35 Asia Pacific Poultry Vaccines market, by country, 2017-2030 (USD Million)
Table 36 Asia Pacific Poultry Vaccines market, by product, 2017-2030 (USD Million)
Table 37 Asia Pacific Poultry Vaccines market, by Disease Type, 2017-2030 (USD Million)
Table 38 Asia Pacific Poultry Vaccines market, by application, 2017-2030 (USD Million)
Table 39 China Poultry Vaccines market, by product, 2017-2030 (USD Million)
Table 40 China Poultry Vaccines market, by Disease Type, 2017-2030 (USD Million)
Table 41 China Poultry Vaccines market, by application, 2017-2030 (USD Million)
Table 42 Japan Poultry Vaccines market, by product, 2017-2030 (USD Million)
Table 43 Japan Poultry Vaccines market, by Disease Type, 2017-2030 (USD Million)
Table 44 Japan Poultry Vaccines market, by application, 2017-2030 (USD Million)
Table 45 India Poultry Vaccines market, by product, 2017-2030 (USD Million)
Table 46 India Poultry Vaccines market, by Disease Type, 2017-2030 (USD Million)
Table 47 India Poultry Vaccines market, by application, 2017-2030 (USD Million)
Table 48 Australia Poultry Vaccines market, by product, 2017-2030 (USD Million)
Table 49 Australia Poultry Vaccines market, by Disease Type, 2017-2030 (USD Million)
Table 50 Australia Poultry Vaccines market, by application, 2017-2030 (USD Million)
Table 51 Global Poultry Vaccines market, by product, 2017-2030 (USD Million)
Table 52 Global Poultry Vaccines market, by Disease Type, 2017-2030 (USD Million)
Table 53 Global Poultry Vaccines market, by application, 2017-2030 (USD Million)
Table 54 Latin America Poultry Vaccines market, by country, 2017-2030 (USD Million)
Table 55 Latin America Poultry Vaccines market, by product, 2017-2030 (USD Million)
Table 56 Latin America Poultry Vaccines market, by Disease Type, 2017-2030 (USD Million)
Table 57 Latin America Poultry Vaccines market, by application, 2017-2030 (USD Million)
Table 58 Brazil Poultry Vaccines market, by product, 2017-2030 (USD Million)
Table 59 Brazil Poultry Vaccines market, by Disease Type, 2017-2030 (USD Million)
Table 60 Brazil Poultry Vaccines market, by application, 2017-2030 (USD Million)
Table 61 Mexico Poultry Vaccines market, by product, 2017-2030 (USD Million)
Table 62 Mexico Poultry Vaccines market, by Disease Type, 2017-2030 (USD Million)
Table 63 Mexico Poultry Vaccines market, by application, 2017-2030 (USD Million)
Table 64 Argentina Poultry Vaccines market, by product, 2017-2030 (USD Million)
Table 65 Argentina Poultry Vaccines market, by Disease Type, 2017-2030 (USD Million)
Table 66 Argentina Poultry Vaccines market, by application, 2017-2030 (USD Million)
Table 67 MEA Poultry Vaccines market, by country, 2017-2030 (USD Million)
Table 68 MEA Poultry Vaccines market, by product, 2017-2030 (USD Million)
Table 69 MEA Poultry Vaccines market, by Disease Type, 2017-2030 (USD Million)
Table 70 MEA Poultry Vaccines market, by application, 2017-2030 (USD Million)
Table 71 South Africa Poultry Vaccines market, by product, 2017-2030 (USD Million)
Table 72 South Africa Poultry Vaccines market, by Disease Type, 2017-2030 (USD Million)
Table 73 South Africa Poultry Vaccines market, by application, 2017-2030 (USD Million)
Table 74 Saudi Arabia Poultry Vaccines market, by product, 2017-2030 (USD Million)
Table 75 Saudi Arabia Poultry Vaccines market, by Disease Type, 2017-2030 (USD Million)
Table 76 Saudi Arabia Poultry Vaccines market, by application, 2017-2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Commodity workflow analysis
Fig. 9 Poultry Vaccines market snapshot, 2021 (USD Million)
Fig. 10 Poultry Vaccines market segmentation and scope
Fig. 11 Parent market outlook
Fig. 12 Ancillary market outlook
Fig. 13 Penetration & growth prospect mapping, 2021
Fig. 14 Poultry Vaccines market dynamics analysis
Fig. 15 Poultry Vaccines market driver analysis
Fig. 16 Poultry Vaccines market restraint analysis
Fig. 17 COVID-19 disease prevalence
Fig. 18 Poultry Vaccines market: Product movement analysis, 2021 & 2030
Fig. 19 Poultry Vaccines market: Product outlook: Key takeaways
Fig. 20 Attenuated Live Vaccines market, 2017 - 2030 (USD Million)
Fig. 21 Inactivated Vaccines market, 2017 - 2030 (USD Million)
Fig. 22 Subunit Vaccines market, 2017 - 2030 (USD Million)
Fig. 23 DNA Vaccines market, 2017 - 2030 (USD Million)
Fig. 24 Recombinant Vaccines market, 2017 - 2030 (USD Million)
Fig. 25 Poultry Vaccines market: Disease Type movement analysis 2021 & 2030
Fig. 26 Poultry Vaccines market: Disease Type outlook: Key takeaways
Fig. 27 Infectious Bronchitis market, 2017 - 2030 (USD Million)
Fig. 28 Infectious Bursal Diseases market, 2017 - 2030 (USD Million)
Fig. 29 Infectious Laryngotracheitis market, 2017 - 2030 (USD Million)
Fig. 30 Egg Drop Syndrome market, 2017 - 2030 (USD Million)
Fig. 31 Adenovirus market, 2017 - 2030 (USD Million)
Fig. 32 Duck Viral Enteritis market, 2017 - 2030 (USD Million)
Fig. 33 Inclusion Body Hepatitis market, 2017 - 2030 (USD Million)
Fig. 34 Coccidiosis market, 2017 - 2030 (USD Million)
Fig. 35 Avian Influenza market, 2017 - 2030 (USD Million)
Fig. 36 Marek's Disease market, 2017 - 2030 (USD Million)
Fig. 37 Newcastle Disease market, 2017 - 2030 (USD Million)
Fig. 38 Salmonella market, 2017 - 2030 (USD Million)
Fig. 39 Avian Encephalomyelitis market, 2017 - 2030 (USD Million)
Fig. 40 Fowl Cholera market, 2017 - 2030 (USD Million)
Fig. 41 Poultry Vaccines market: Application movement analysis, 2021 & 2030
Fig. 42 Poultry Vaccines market application outlook: Key takeaways
Fig. 43 Broiler market, 2017 - 2030 (USD Million)
Fig. 44 Layer market, 2017 - 2030 (USD Million)
Fig. 45 Breeder market, 2017 - 2030 (USD Million)
Fig. 46 Poultry Vaccines market: Regional movement analysis 2021 & 2030
Fig. 47 Poultry Vaccines market regional outlook: Key takeaways
Fig. 48 North America Poultry Vaccines market share, by country, 2021
Fig. 49 North America Poultry Vaccines market, 2017 - 2030 (USD Million)
Fig. 50 U.S. Poultry Vaccines market, 2017 - 2030 (USD Million)
Fig. 51 Canada Poultry Vaccines market, 2017 - 2030 (USD Million)
Fig. 52 Europe Poultry Vaccines market share, by country, 2021
Fig. 53 Europe Poultry Vaccines market, 2017 - 2030 (USD Million)
Fig. 54 Germany Poultry Vaccines market, 2017 - 2030 (USD Million)
Fig. 55 France Poultry Vaccines market, 2017 - 2030 (USD Million)
Fig. 56 U.K. Poultry Vaccines market, 2017 - 2030 (USD Million)
Fig. 57 Italy Poultry Vaccines market, 2017 - 2030 (USD Million)
Fig. 58 Spain Poultry Vaccines market, 2017 - 2030 (USD Million)
Fig. 59 Russia Poultry Vaccines market, 2017 - 2030 (USD Million)
Fig. 60 Asia Pacific Poultry Vaccines market share, by country, 2021
Fig. 61 Asia Pacific Poultry Vaccines market, 2017 - 2030 (USD Million)
Fig. 62 Japan Poultry Vaccines market, 2017 - 2030 (USD Million)
Fig. 63 China Poultry Vaccines market, 2017 - 2030 (USD Million)
Fig. 64 India Poultry Vaccines market, 2017 - 2030 (USD Million)
Fig. 65 Australia Poultry Vaccines market, 2017 - 2030 (USD Million)
Fig. 66 Latin America Poultry Vaccines market share, by country, 2021
Fig. 67 Latin America Poultry Vaccines market, 2017 - 2030 (USD Million)
Fig. 68 Brazil Poultry Vaccines market, 2017 - 2030 (USD Million)
Fig. 69 Mexico Poultry Vaccines market, 2017 - 2030 (USD Million)
Fig. 70 Argentina Poultry Vaccines market, 2017 - 2030 (USD Million)
Fig. 71 MEA Poultry Vaccines market share, by country, 2021
Fig. 72 MEA Poultry Vaccines market, 2017 - 2030 (USD Million)
Fig. 73 South Africa Poultry Vaccines market, 2017 - 2030 (USD Million)
Fig. 74 Saudi Arabia Poultry Vaccines market, 2017 - 2030 (USD Million)
Fig. 75 Market participant categorization
Fig. 76 Company market position analysis

Companies Mentioned

  • Boehringer Ingelheim International GmbH
  • Ceva
  • Zoetis
  • Elanco
  • Intervet Inc., a Subsidiary of Merck & Co., Inc.
  • Hester Biosciences Limited
  • Vaxxinova International BV
  • Venkys India
  • Calier
  • KM Biologics
  • Phibro Animal Health Corporation

Methodology

Loading
LOADING...

Table Information